Figure 3
From: Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients
Probability of persistence according to the cause of withdrawal of last anti-TNF. The persistence did not show statistical differences among patients who stopped prior anti-TNF by primary failure, secondary failure or other causes (p = 0.53 by log-rank test). Statistical analysis was performed using R Software13.
